LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit

Stock Information for Lifecore Biomedical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lifecore Biomedical Inc.

LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
DEADLINE ALERT for CAE, AAL, ODD, LFCR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
A Securities Fraud Case Has Been Filed Against Lifecore Biomedical Inc And The Schall Law Firm Urges Investor Participation
DEADLINE ALERT for CAE, AAL, ODD, and LFCR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LFCR DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action - LFCR
Lifecore Biomedical, Inc. Is Being Sued For Possible Securities Law Violations And Affected Shareholders Are Invited To Contact The Schall Law Firm

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.